• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金属健康风险评估中的物种形成:对与环境中存在的形态相关的影响的评估。

Speciation in health risk assessments of metals: evaluation of effects associated with forms present in the environment.

作者信息

Hughes K, Meek M E, Newhook R, Chan P K

机构信息

Environmental Health Directorate, Health Canada, Ottawa, Ontario.

出版信息

Regul Toxicol Pharmacol. 1995 Dec;22(3):213-20. doi: 10.1006/rtph.1995.0003.

DOI:10.1006/rtph.1995.0003
PMID:8837845
Abstract

Because metals occur in various forms in the environment, speciation is an issue which must be addressed in regulatory health risk assessment programs. The manner in which speciation was addressed in a federal program in Canada is discussed in this article. Under the Canadian Environmental Protection Act, four metals, including arsenic, cadmium, chromium, and nickel, and their compounds were assessed as priority substances to determine the risk to human health associated with exposure to levels present in the general environment in Canada. The extent to which the speciation of these metals could be considered in these assessments was largely determined by the nature of available data. Very few data were identified on speciation in environmental media to which humans are exposed. Based on available data on health effects, it was possible to conduct assessments on only one form each of arsenic and cadmium (i.e., inorganic arsenic and inorganic cadmium), two forms of chromium (trivalent and hexavalent), and four forms of inorganic nickel (oxidic, sulfidic, soluble, and metallic.

摘要

由于金属在环境中以多种形式存在,形态分析是监管健康风险评估计划中必须解决的一个问题。本文讨论了加拿大一项联邦计划中处理形态分析的方式。根据《加拿大环境保护法》,包括砷、镉、铬和镍在内的四种金属及其化合物被评估为优先物质,以确定与接触加拿大一般环境中存在的水平相关的对人类健康的风险。在这些评估中能够考虑这些金属形态的程度在很大程度上取决于现有数据的性质。在人类接触的环境介质中的形态分析方面,几乎没有找到相关数据。根据关于健康影响的现有数据,仅能对砷和镉的每种一种形态(即无机砷和无机镉)、两种铬形态(三价和六价)以及四种无机镍形态(氧化态、硫化态、可溶态和金属态)进行评估。

相似文献

1
Speciation in health risk assessments of metals: evaluation of effects associated with forms present in the environment.金属健康风险评估中的物种形成:对与环境中存在的形态相关的影响的评估。
Regul Toxicol Pharmacol. 1995 Dec;22(3):213-20. doi: 10.1006/rtph.1995.0003.
2
Approach to health risk determination for metals and their compounds under the Canadian Environmental Protection Act.根据《加拿大环境保护法》确定金属及其化合物健康风险的方法。
Regul Toxicol Pharmacol. 1995 Dec;22(3):206-12. doi: 10.1006/rtph.1995.0002.
3
The speciation of metals in mammals influences their toxicokinetics and toxicodynamics and therefore human health risk assessment.哺乳动物体内金属的形态会影响其毒代动力学和毒效动力学,进而影响人类健康风险评估。
J Toxicol Environ Health B Crit Rev. 2006 Jan-Feb;9(1):63-85. doi: 10.1080/15287390500196230.
4
The value of metals bioavailability and speciation information for ecological risk assessment in arid soils.干旱土壤中金属生物有效性和形态信息在生态风险评估中的价值。
Integr Environ Assess Manag. 2006 Oct;2(4):355-64.
5
Potential health risks related to carcinogens in the atmospheric environment in India.印度大气环境中与致癌物相关的潜在健康风险。
Regul Toxicol Pharmacol. 1996 Oct;24(2 Pt 1):141-8. doi: 10.1006/rtph.1996.0119.
6
Metals and women's health.金属与女性健康。
Environ Res. 2002 Mar;88(3):145-55. doi: 10.1006/enrs.2002.4338.
7
Environmental metallic carcinogens: an overview of exposure levels.环境金属致癌物:暴露水平概述
J Toxicol Environ Health. 1976 Sep;2(1):77-109. doi: 10.1080/15287397609529419.
8
Lung cancer and exposure to metals: the epidemiological evidence.肺癌与金属暴露:流行病学证据
Methods Mol Biol. 2009;472:139-67. doi: 10.1007/978-1-60327-492-0_6.
9
Toxicological principles of metal carcinogenesis with special emphasis on cadmium.金属致癌作用的毒理学原理,特别强调镉。
Crit Rev Toxicol. 1992;22(3-4):175-201. doi: 10.3109/10408449209145323.
10
Epidemiology and the identification of metals as human carcinogens.流行病学与金属作为人类致癌物的鉴定
Sci Prog. 1996;79 ( Pt 4):311-26.